| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 189.34B | 185.23B | 213.67B | 240.86B | 154.71B |
| Gross Profit | 33.53B | 28.11B | 47.39B | 54.05B | 21.65B |
| EBITDA | 31.07B | 25.11B | 42.89B | 29.37B | 27.82B |
| Net Income | 55.00M | 382.83M | 15.50B | -2.48B | 7.42B |
Balance Sheet | |||||
| Total Assets | 278.53B | 282.23B | 280.29B | 288.12B | 287.27B |
| Cash, Cash Equivalents and Short-Term Investments | 36.71B | 34.52B | 28.59B | 29.77B | 30.96B |
| Total Debt | 72.53B | 71.55B | 63.08B | 55.49B | 69.79B |
| Total Liabilities | 204.53B | 203.91B | 194.80B | 205.13B | 196.83B |
| Stockholders Equity | 53.05B | 59.25B | 70.28B | 67.55B | 75.46B |
Cash Flow | |||||
| Free Cash Flow | 11.27B | 12.00B | 17.75B | 28.86B | 12.72B |
| Operating Cash Flow | 24.49B | 27.30B | 32.04B | 40.93B | 23.61B |
| Investing Cash Flow | -11.50B | -13.25B | -14.87B | -13.71B | -5.69B |
| Financing Cash Flow | -15.88B | -7.30B | -13.36B | -28.02B | -18.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £176.65B | 13.38 | 8.25% | 4.00% | -9.21% | -2.61% | |
73 Outperform | £1.66B | 10.11 | 17.24% | 10.99% | -2.66% | 0.11% | |
70 Outperform | £2.58B | 20.43 | 12.03% | 5.64% | 159.13% | 143.76% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
63 Neutral | £4.95B | -11.95 | -11.32% | 8.77% | 123.03% | -330.89% | |
60 Neutral | £74.98B | 1,837.12 | 2.40% | 5.73% | -6.90% | -43.82% | |
54 Neutral | £3.87B | -44.07 | -4.67% | 14.05% | 63.10% | -161.03% |